Release Date: Apr 2019
CC: PC, MK, PBL, ICS, SBP
Rory Welsh, PhD
Microbiologist, CDC, Atlanta, GA
After completing this course, participants will be able to:
- Describe the current recommendations for identification of Candida auris.
- Locate and access national established guidelines for reporting the laboratory diagnosis of Candida auris to the appropriate public health agencies.
- Describe the current recommendations for infection prevention and control for Candida auris, e.g., cleaning and disinfecting the lab and patient care environment (daily and terminal cleaning) with recommended products, screening of contacts, etc.
Who should attend? Practicing Pathologists, Residents, Doctoral Scientists, Pathologists’ Assistants, Laboratory Managers, Bench Supervisors, Bench Technologists & Technicians, Histotechnologists, Students
Candida auris is an emerging fungal pathogen that can spread in healthcare settings. It is often multidrug-resistant, meaning that it is resistant to multiple antifungal drugs commonly used to treat Candida infections. It is difficult to identify with standard laboratory methods, and it can be misidentified in labs without specific technology. Misidentification of this yeast may lead to inappropriate management. It has caused outbreaks in healthcare settings. For this reason, it is important to quickly identify C. auris in a hospitalized patient so that healthcare facilities can take special precautions to stop its spread. Herein, participating attendees will be presented with the current recommendations for identification, reporting, disinfection, and infection prevention and control for C. auris.
Recommendation for identification of Candida auris:
Summarize common mis-identifications based on the identification method used, and describe diagnostic devices and methods that can accurately identify C. auris.
Recommendations for Infection Prevention and Control for Candida auris:
Emphasize adherence to hand hygiene and using standard and contact precautions.
Cleaning and disinfecting the lab and patient care environment (daily and terminal cleaning) with recommended products.
Methods for screening patients to identify C. auris colonization, because colonized patients can be a source of C. auris transmission.